Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Feldman

Showing results (51-60 of 280) with videos related to

Pageof 28
Sort By:
Arthritis Care & Research|August 29, 2015
ReplyRohit Aggarwal, Tuhina Neogi, Sindhu R Johnson, et al.
Arthritis and Rheumatism|June 26, 2008
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysisRoopa Seshadri, Brian M Feldman, Norman Ilowite, et al.
The Journal of Rheumatology|December 2, 2008
Shifting our thinking about uncommon disease trials: the case of methotrexate in sclerodermaSindhu R Johnson, Brian M Feldman, Janet E Pope, et al.
The Journal of Rheumatology|October 6, 2005
Eye findings in patients with juvenile dermatomyositisJonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|August 20, 2002
Clinical assessment of conjunctival and episcleral vessel tortuosity in juvenile dermatomyositisTara A Young, Sualiman Al-Mayouf, Brian M Feldman, et al.
The Journal of Rheumatology|February 4, 2003
Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvementHermine I Brunner, Brian M Feldman, Murray B Urowitz, et al.
Pediatric Rheumatology Online Journal|May 4, 2021
Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper formsJennifer Y Yu, Talia Goldberg, Nicholas Lao, et al.
The Journal of Pediatrics|November 3, 2004
Clinical and cost implications of target joints in Canadian boys with severe hemophilia AMelissa Kern, Victor Blanchette, Ann Marie Stain, et al.
Arthritis and Rheumatism|February 13, 2002
Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damageHermine I Brunner, Earl D Silverman, Theresa To, et al.
The Journal of Rheumatology|August 3, 2016
The Responsiveness of the Modified Childhood Health Assessment QuestionnaireShannon Peters, Sylvia Ota, Emily Bolous, et al.
Pageof 28

Showing results (51-60 of 280) with videos related to

Sort By:
Pageof 28
Arthritis Care & Research|August 29, 2015
ReplyRohit Aggarwal, Tuhina Neogi, Sindhu R Johnson, et al.
Arthritis and Rheumatism|June 26, 2008
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysisRoopa Seshadri, Brian M Feldman, Norman Ilowite, et al.
The Journal of Rheumatology|December 2, 2008
Shifting our thinking about uncommon disease trials: the case of methotrexate in sclerodermaSindhu R Johnson, Brian M Feldman, Janet E Pope, et al.
The Journal of Rheumatology|October 6, 2005
Eye findings in patients with juvenile dermatomyositisJonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|August 20, 2002
Clinical assessment of conjunctival and episcleral vessel tortuosity in juvenile dermatomyositisTara A Young, Sualiman Al-Mayouf, Brian M Feldman, et al.
The Journal of Rheumatology|February 4, 2003
Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvementHermine I Brunner, Brian M Feldman, Murray B Urowitz, et al.
Pediatric Rheumatology Online Journal|May 4, 2021
Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper formsJennifer Y Yu, Talia Goldberg, Nicholas Lao, et al.
The Journal of Pediatrics|November 3, 2004
Clinical and cost implications of target joints in Canadian boys with severe hemophilia AMelissa Kern, Victor Blanchette, Ann Marie Stain, et al.
Arthritis and Rheumatism|February 13, 2002
Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damageHermine I Brunner, Earl D Silverman, Theresa To, et al.
The Journal of Rheumatology|August 3, 2016
The Responsiveness of the Modified Childhood Health Assessment QuestionnaireShannon Peters, Sylvia Ota, Emily Bolous, et al.
Pageof 28